Hep C Antibody Test

The Hepatitis C Antibody Test detects antibodies against the hepatitis C virus (HCV). This test helps diagnose hepatitis C infection and determine the immune response to the virus.

Who would benefit from this test?

Individuals at risk for hepatitis C infection, such as those with a history of injection drug use or unprotected sex with multiple partners.

Patients with symptoms of acute or chronic hepatitis C infection, including fatigue or liver abnormalities.

Individuals who require screening for hepatitis C as part of a routine health assessment.

People with known exposure to hepatitis C-infected blood or body fluids.

Individuals with risk factors for hepatitis C, such as having received blood transfusions before 1992.

Why undertake this test?

To diagnose acute or chronic hepatitis C infection.

To assess the immune response to the hepatitis C virus.

To monitor the effectiveness of hepatitis C treatment.

To identify individuals at risk for hepatitis C and guide preventive measures.

To provide appropriate medical care and management for hepatitis C infection.

Test Type: Serology

Results Estimated: 2 Working days.

A little more detail:

The Hepatitis C Antibody test is essential for identifying exposure to hepatitis C, a viral infection that primarily affects the liver and can lead to severe complications if untreated. This test detects antibodies the immune system produces in response to the virus, which typically develop a few weeks to months post-exposure. A positive result doesn’t necessarily confirm an active infection but indicates past exposure, prompting additional tests to assess whether the infection is ongoing. The anti-HCV test is particularly beneficial for those with increased exposure risks, such as people who inject drugs, healthcare workers, or individuals born during certain high-risk years. Given that hepatitis C is often asymptomatic until severe liver damage occurs, screening and early detection play critical roles in effective treatment and management. Early diagnosis allows healthcare providers to initiate antiviral treatments that can prevent the progression to chronic liver disease, improve quality of life, and reduce the risk of transmission.